Key facts
- This page summarizes Scott R. Pancoast's Form 4 filing for DermTech, Inc..
- 3 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 02 Jul 2021, 20:50.
Scott R. Pancoast - 30 Jun 2021 Form 4 Insider Report for DermTech, Inc.
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 30 Jun 2021
- Net transaction value
- -$212,051
- SEC form
- 4
- Accepted by SEC
- 02 Jul 2021, 20:50:08 UTC
- Prior SEC filing
- 28 May 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jason S. Miller, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Scott R. Pancoast filed Form 4 for DermTech, Inc. on 02 Jul 2021.
Change
- Previous filing in this sequence was filed on 28 May 2021.
- Current net transaction value: -$212,051.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
DMTK
transaction
Common Stock
Sale
- Transaction value
- $194,912
- Shares
- -4,606
- Change %
- -8.6%
- Price
- $42.32
- Shares after
- 48,684
- Date
- 30 Jun 2021
- Ownership
- Direct
- Footnotes
- F1, F2
DMTK
transaction
Common Stock
Sale
- Transaction value
- $17,139
- Shares
- -394
- Change %
- -0.81%
- Price
- $43.50
- Shares after
- 48,290
- Date
- 30 Jun 2021
- Ownership
- Direct
- Footnotes
- F1
DMTK
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +2,406
- Change %
- +5%
- Price
- $0.000000
- Shares after
- 50,696
- Date
- 01 Jul 2021
- Ownership
- Direct
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Scott R. Pancoast is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 3 footnotes
Footnote F1
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 26, 2021.
Footnote F2
This transaction was executed in multiple trades at prices ranging from $42.08 to $42.85, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Footnote F3
The securities awarded are in the form of restricted stock units issued pursuant to the issuer's 2020 Equity Incentive Plan. Each restricted stock unit represents a right to receive one share of issuer common stock. The award will vest in full and be released at the next annual meeting of stockholders of the Company.